amavita CardioElite™ SNF Program
The Nation's First Cardiovascular Management Program for Skilled Nursing Facilities, Powered by Cutting-Edge AI Technology
Harnessing the Latest AI Innovations to Transform Your Facility Into a Cardiovascular Center of Excellence
About Us
Cardiovascular Excellence
Founded by leading cardiologists, amavita CardioElite™ combines profound clinical expertise with cutting-edge AI technology and innovative tools to transform post-acute cardiac care.
Innovation Leaders
Our pioneering AI-powered cardiac diagnostics system utilizes the latest AI innovations available in the market. Developed specifically for the SNF environment, it allows for earlier detection and intervention without hospital transfer.
Dedicated Partners
We're committed to transforming your facility into a cardiovascular center of excellence through comprehensive training, 24/7 clinical support, and certification guidance. We ensure you benefit from our continuously evolving AI capabilities.
Meet Dr. Pedro Martinez-Clark
Clinical Excellence
A Harvard-trained interventional cardiologist with 27+ years of experience, Dr. Martinez-Clark brings world-class expertise. His credentials include:
- Board-certified in 3 specialties
- 12,000+ minimally invasive procedures
Business Success
As founder of amavita Heart and Vascular Health®, he transformed a practice into a comprehensive cardiovascular leader, opening:
- 15,000 sq ft Miami Cardiovascular ASC
- 20,000 sq ft Aventura Medical Tower Surgery Center
- Oversaw 12,000+ procedures across platform
Innovation & Leadership
Dr. Martinez-Clark drives innovation and community impact by spearheading the incorporation of the latest AI innovations and ensuring continuously evolving AI capabilities for the CardioElite™ program:
- AI Technology Pioneer: Implemented AISAP, a proprietary, cutting-edge AI technology for cardiac diagnostics, ensuring rapid, accurate point-of-care diagnosis.
- Amavita Foundation Leader: Spearheads initiatives like MISA to reduce amputations by addressing healthcare disparities.
Partnering for Excellence
Transform your skilled nursing facility with amavita Heart and Vascular Health®, the leaders in AI-forward cardiovascular care. We utilize cutting-edge AI technology and are constantly incorporating the latest AI innovations into our CardioElite™ program. This commitment to continuously evolving AI capabilities allows us to elevate patient outcomes and boost your facility's reputation, all without any additional investment in capital or staff.
The Cardiovascular Crisis in SNFs
+33%
Rehospitalization Rate
of heart failure patients in SNFs are readmitted within 30 days
53.5%
Mortality Rate
at one year for cardiac patients in SNFs
$16K
Cost Per Case
average cost per cardiovascular hospitalization
25%
Patient Volume
of all HF patients are discharged to SNFs, creating massive demand
Addressing this crisis requires innovative solutions. Amavita's CardioElite™ program leverages cutting-edge AI technology and continuously incorporates the latest AI innovations to provide superior cardiovascular care and dramatically improve these statistics, positioning us as technology leaders at the forefront of AI advancements.
Two Core Pillars of Our AI-Powered Program
The amavita CardioElite™ program is meticulously designed to address critical cardiovascular challenges within Skilled Nursing Facilities (SNFs). Built upon the foundation of cutting-edge AI technology and continuously evolving capabilities, our solution targets two primary areas crucial for enhancing patient outcomes and operational efficiency, leveraging the latest AI innovations to transform care delivery.
Congestive Heart Failure (CHF) Management
Our advanced AI diagnostics, including the FDA-approved AISAP platform, provide rapid, precise point-of-care assessment for CHF. This enables SNF staff to implement personalized treatment plans swiftly, optimize medication regimens, and proactively monitor patient status. By identifying decompensation early, CardioElite™ significantly reduces rehospitalization rates for CHF patients, ensuring they receive the highest standard of care within your facility.
Cardiovascular Fall Prevention Management
Falls in SNFs are often linked to undiagnosed or poorly managed cardiovascular conditions. CardioElite™ incorporates comprehensive cardiac assessments to identify underlying risk factors such as arrhythmias, orthostatic hypotension, and other cardiac issues contributing to falls. Through proactive screening and tailored interventions, we empower your team to minimize fall incidents, improve patient safety, and enhance the overall quality of life for residents.
These two pillars form the core of our commitment to elevating cardiovascular care, reducing adverse events, and positioning your facility as a leader in post-acute cardiac health.
The amavita CardioElite™ Solution
CUTTING-EDGE AI TECHNOLOGY & CONTINUOUSLY EVOLVING CAPABILITIES
Partnership utilizing the latest AI innovations: AISAP's FDA-approved AI ultrasound diagnostic platform
AI enables rapid point-of-care diagnosis for structural heart disease and heart failure
AI-powered speed: From scan to comprehensive report in minutes, with no specialist required on-site
Real-time AI scanning assistance ensures accurate imaging and consistent quality
Comprehensive Program Components
Cutting-Edge AI Diagnostics
First-of-its-kind implementation of cutting-edge AI technology in ultrasound diagnostics at the bedside, leveraging our continuously evolving AI capabilities.
Heart Failure Certification
Pathway to Heart Failure and Stroke Certification for your facility, backed by superior diagnostic technology.
Staff Training & Education
Comprehensive cardiovascular education program for your nursing and clinical staff, utilizing the latest AI innovations for enhanced learning.
CHF Management Protocols
Comprehensive Congestive Heart Failure (CHF) care protocols integrated with cutting-edge AI technology for continuous monitoring, predictive analytics, and personalized intervention strategies.
Cardiovascular Fall Prevention
Utilizing AI-driven cardiac monitoring and intervention insights to identify high-risk patients and implement proactive strategies, significantly reducing cardiovascular-related falls.
Advanced Arrhythmia Screening
Detailed arrhythmia screening and treatment protocols, supported by cutting-edge AI analysis for rapid and accurate detection of complex cardiac rhythm disorders.
What This Means for Your Facility
These proven financial and operational improvements are a direct result of Amavita’s commitment to adopting the latest AI innovations and maintaining continuously evolving AI capabilities at the forefront of cardiovascular care.
Financial Impact
- Monthly savings: $20,640 (24 patients × $860)
- Annual savings: $247,680
- ROI: Immediate positive return on investment
Operational Benefits
- Reduced emergency transfers: Fewer middle-of-the-night ambulance calls
- Lower staff stress: Less crisis management and family communications
- Improved census stability: Patients stay longer and recover better
- Enhanced reputation: Lower readmission rates improve your facility's quality ratings
What the Numbers Actually Mean
The $860 savings figure is based on a published research study on virtual cardiovascular programs in skilled nursing facilities, now powered by our cutting-edge AI technology and continuously evolving AI capabilities. Here's how the savings are calculated:
1
Understand the Reduction via AI
Before CardioElite™ (utilizing the latest AI innovations for predictive analytics), 27 out of 100 patients were readmitted. After implementation, this drops to 18 out of 100 patients, representing a 9% reduction in readmissions.
2
Calculate Total Savings
With an average cost of $9,600 per readmission (based on study data), this translates to a total savings of $86,400 per 100 patients.
3
Savings Per Patient
By dividing the total savings of $86,400 by 100 patients, we arrive at an approximate savings of $864 per individual patient, rounded to $860.
Amavita: Technology Leaders at the Forefront of Care
The success of CardioElite™ is powered by our commitment to integrating cutting-edge AI technology. We leverage the latest AI innovations available in the market and ensure our platform features continuously evolving AI capabilities to provide the best cardiovascular care possible.
Strategic Value for SNF Administrators
Amavita's CardioElite™ program is built on cutting-edge AI technology and is continuously incorporating new AI tools to maximize the strategic value for your facility.
Direct Cost Avoidance
- Lost revenue during patient's absence
- Administrative costs of coordinating transfers
- Staff overtime for emergency situations
- Potential penalties under CMS Value-Based Purchasing programs
Competitive Advantage
- Hospitals prefer partnering with SNFs that boast lower readmission rates, achieved through Amavita's cutting-edge AI technology.
- Higher quality scores improve your facility's marketability, driven by our continuously evolving AI capabilities.
- Better outcomes lead to increased referrals from discharge planners, establishing your facility as a leader in leveraging the latest AI innovations for superior patient care.
Who Benefits?
YOUR FACILITY
Reduce Hospital Readmissions
Achieve industry-leading low readmission rates powered by our cutting-edge AI technology.
Market Differentiation
Become the region's premier cardiovascular SNF, recognized for leveraging the latest AI innovations.
Increased Referrals
Attract increased referrals by demonstrating specialized capabilities and continuously evolving AI capabilities.
Heart Failure Certification
Join elite facilities achieving Heart Failure Center designation through AI-forward, technology-led care.
Your Patients
Earlier Detection: Cutting-edge AI technology identifies cardiac issues before a crisis occurs
Better Outcomes: Evidence-based care protocols, informed by the latest AI innovations, improve survival rates
Continuity of Care: Seamless coordination from admission through discharge, supported by our continuously evolving AI capabilities
Payers & Hospitals
Cost Reduction
Prevent expensive emergency readmissions through predictive modeling powered by cutting-edge AI technology.
Quality Metrics
Improve hospital quality scores by leveraging the latest AI innovations for enhanced patient monitoring and post-acute partnerships.
Value-Based Care
Align with Medicare's focus on outcomes over volume using continuously evolving AI capabilities to ensure optimal patient care.
Your Clinical Team
Enhanced Capabilities
Staff empowered with cutting-edge AI technology and diagnostic tools.
Peace of Mind
24/7 cardiovascular expertise and consultation support, continuously updated with the latest AI innovations.
Professional Development
Training in advanced cardiac care management, focusing on amavita's continuously evolving AI capabilities.
Why Choose amavita CardioElite™?
AI TECHNOLOGY LEADERSHIP: Only cardiovascular practice offering cutting-edge AI-powered diagnostics in SNFs, continuously incorporating the latest AI innovations into CardioElite™.
PROVEN EXPERTISE: 15+ years in cardiovascular excellence
CUTTING-EDGE SUPPORT: From deploying the latest AI technology and continuously evolving AI capabilities to comprehensive training and certification.
IMMEDIATE IMPACT: Reduced readmissions within first quarter
SCALABLE SOLUTION: Adaptable to facilities of all sizes
Leadership Team
Dr. Pedro Martinez-Clark, MD, FACC
Founder & Chief Medical Officer
A trailblazing cardiologist with over two decades of expertise. His dedication is focused on harnessing cutting-edge AI technology to redefine cardiovascular diagnostics. His journey began in Colombia, where he honed his skills, before embarking on prestigious training at Harvard and Case Western. Former professor and physician at the University of Miami, he pushed the boundaries of interventional cardiology, mentored by the legendary Dr. William O'Neill.
Dr. Martinez-Clark ensures amavita maintains its position as a technology leader, continuously integrating the latest AI innovations into the CardioElite™ program. His dedication and excellence have earned him the prestigious title of Fellow of the American College of Cardiology (ACC).
Steven Shai Gold
Senior Vice President of Strategic Development & Market Expansion
Steven Shai Gold is a 30-year healthcare executive. He leads Alfa-Strategies, providing advisory services to providers and med-tech. He is focused on the strategic adoption and market expansion of Amavita's technology platform, ensuring wide-scale integration of its continuously evolving AI capabilities. At Jackson Memorial, he grew international services to $90M. He was the Managing Director at Jet Rescue Air Ambulance and SVP at MDabroad, repositioning international medical insurance.
Ron Zelhof
Chief Operating Officer
Ron Zelhof is a 30-year healthcare operations executive. He's currently an Advisory Board Member at amavita Heart and Vascular Health®. Ron served as COO at AirSculpt and SVP at Surgery Partners, overseeing operations and driving efficiencies. His expertise was developed leading transformational initiatives at HealthSouth. Ron ensures operational excellence by implementing best practices rooted in Amavita's AI-forward technology leadership. Ron holds a BS in Education and Physical Therapy, enhancing his understanding of patient care.
amavita CardioElite™ Key Benefits
amavita’s CardioElite™ program is powered by cutting-edge AI technology and is always incorporating the latest AI innovations into its arsenal. We demonstrate continuously evolving AI capabilities, positioning us as technology leaders who stay at the forefront of AI advancements in cardiovascular care.
Readmission Rates: SNF vs CardioElite™
Our superior outcomes, as demonstrated by lower readmission rates, are powered by cutting-edge AI technology. CardioElite™ utilizes the latest AI innovations to personalize patient care and continuously improve predictive accuracy, establishing amavita as a leader at the forefront of AI advancements in cardiovascular care. We are continuously incorporating new AI tools into our arsenal to ensure continuously evolving AI capabilities.
CardioElite™ Program Outcomes
The CardioElite™ program leverages cutting-edge AI technology and incorporates the latest AI innovations available in the market to drive superior results. Amavita is committed to continuously evolving AI capabilities to stay at the forefront of cardiovascular care.
Readmission
Without Program With CardioElite™
Healthcare Metrics
Amavita's CardioElite™ program utilizes latest AI innovations to achieve superior patient outcomes, demonstrating our commitment to being technology leaders at the forefront of AI advancements in cardiovascular care.
43%
Current Readmission Rate
Heart failure patients in SNFs readmitted within 30 days
3%
CardioElite™ Readmission Rate
Reduced cardiac readmissions through program implementation, leveraging cutting-edge AI technology for proactive intervention.
53.5%
Current Mortality Rate
One-year mortality for cardiac patients in SNFs
Reducing Falls Through Cardiovascular Oversight
Beyond traditional safety measures, many "unexplained" falls in skilled nursing facilities have a critical, often overlooked, cardiovascular origin. The amavita CardioElite™ program leverages cutting-edge AI technology to offer a proactive, evidence-based pathway to identify and mitigate these risks, ensuring safer residents and enhancing your facility's quality outcomes. We are continuously incorporating new AI tools to our arsenal.
The Hidden Cause of "Mechanical" Falls
It's estimated that up to 1 in 5 unexplained falls in older adults are caused by cardiac arrhythmias. These irregular heart rhythms can lead to episodes of dizziness or syncope, which are frequently misreported as "just a fall" rather than recognizing the underlying cardiac event. Addressing these rhythm problems through advanced monitoring and appropriate interventions has been demonstrably shown to reduce falls and related fractures.
For instance, the SAFE-PACE trial highlighted how dual-chamber pacing significantly cut falls in fall-prone older adults. Following pacemaker implantation, residents experienced a notable decrease in both falls and fractures, underscoring the vital connection between cardiovascular health and physical stability.
Why This Matters to Your Facility
Ignoring the cardiac link to falls can have significant repercussions for your facility:
- CMS 5-Star Ratings: Falls with injury directly impact your public quality scores, affecting reputation and referrals.
- Survey Risk: Recurrent falls are a red flag during surveys, potentially leading to citations, penalties, and increased liability.
- Readmissions: Each emergency department transfer or hospitalization due to a fall represents a substantial financial and reputational cost.
Our Solution: Cardiovascular Fall-Prevention Pathway
The amavita CardioElite™ program is built on latest AI innovations and implements a structured, five-step pathway to proactively address cardiovascular fall risks, ensuring we stay at the forefront of AI advancements in cardiovascular care:
Screen
On-admission ECG and orthostatic vitals identify high-risk residents early in their stay.
Monitor & Analyze
Rapid access to mobile cardiac telemetry (MCT) or patch telemetry for recurrent fallers, with AI-driven analysis providing actionable insights alongside thorough device interrogation.
Triage
An ARNP-led evaluation, augmented by continuously evolving AI capabilities for rapid rhythm detection, guided by cardiologist oversight, allows for timely interventions.
Treat
Expedited referral for cardiac pacing or other rhythm management therapies when clinically indicated.
Measure
Quarterly reporting provides transparent data on faller screening rates, arrhythmias detected, ED transfers avoided, and the overall reduction in falls and fractures.
The Value to Your Facility
By integrating amavita CardioElite™ into your care model, your facility stands to gain:
Fewer Falls & Injuries
Protect residents from dangerous falls by addressing underlying cardiac causes.
Reduced Hospital Readmissions
Minimize costly and disruptive transfers to acute care facilities.
Protected CMS 5-Star Rating
Maintain and improve your facility's public quality indicators.
Stronger Survey Readiness
Demonstrate robust protocols for resident safety and quality care.
Peace of Mind
Offer residents and their families confidence in a proactive and secure care environment.
Partner With Us
Our CardioElite™ SNF Program provides a comprehensive support system, including:
- Dedicated ARNPs on-site for daily cardiovascular oversight
- Supervising cardiologists for advanced review and compliance
- Proven protocols leveraging cutting-edge AI tools that align with CMS quality initiatives and best practices
Optimizing Heart Failure Management with Furosemide
In the management of heart failure within Skilled Nursing Facilities (SNFs), precise pharmacological intervention is paramount to patient stability and quality of life. The amavita CardioElite™ program leverages evidence-based protocols and cutting-edge AI technology, including the judicious use of furosemide, to effectively manage fluid overload, a hallmark symptom of heart failure. This targeted approach not only alleviates distressing symptoms but also significantly contributes to the overall well-being and longevity of residents.
Furosemide, a potent loop diuretic, plays a critical role in reducing excess fluid accumulation in patients with heart failure. Its proper administration and diligent monitoring are crucial to prevent complications such as electrolyte imbalances and renal dysfunction, while ensuring optimal therapeutic effect. By controlling volume status, amavita CardioElite™ aims to prevent exacerbations that often lead to acute hospitalizations.
Reduced Hospital Readmissions
Effective furosemide management prevents fluid overload, a primary driver of heart failure exacerbations and subsequent emergency department visits and hospitalizations.
Improved Symptom Control
Alleviates common heart failure symptoms like dyspnea, edema, and fatigue, leading to greater comfort and functional independence for residents.
Enhanced Quality of Life
By stabilizing cardiac function and reducing discomfort, residents experience a significantly improved quality of life, allowing for more engagement in daily activities.
Cardiovascular Stability
Careful titration and monitoring of furosemide support overall cardiovascular stability, reducing the burden on the heart and improving long-term outcomes.
Our structured approach, driven by continuously evolving AI capabilities, ensures that each resident receives individualized furosemide dosing and monitoring, guided by clinical expertise and a commitment to patient safety. This proactive strategy underscores amavita CardioElite™'s dedication to delivering superior cardiac care in the SNF setting, positioning us as technology leaders who stay at the forefront of AI advancements in cardiovascular care.
Advanced Arrhythmia Screening: Proactive Cardiac Monitoring
The amavita CardioElite™ program introduces advanced arrhythmia screening into Skilled Nursing Facilities (SNFs), leveraging cutting-edge AI technology and diagnostic tools to proactively identify irregular heart rhythms. This crucial early detection mechanism is instrumental in preventing severe complications, significantly reducing fall incidents, and ultimately enhancing patient outcomes. Irregular heartbeats, often subtle and intermittent, can go unnoticed until a serious event occurs, such as a syncopal episode leading to a fall, or a cerebrovascular accident.
Our state-of-the-art technology, powered by continuously evolving AI capabilities, provides continuous, non-invasive monitoring, capturing transient arrhythmias that might be missed during routine examinations. By establishing a baseline of cardiac electrical activity and promptly signaling anomalies through sophisticated machine learning algorithms, the system empowers clinical teams to intervene decisively. This proactive, AI-driven approach allows for the identification of dangerous arrhythmias, such as atrial fibrillation, ventricular tachycardias, and significant bradycardias, before they precipitate falls, strokes, or other life-threatening cardiac events. Integration with our CardioElite™ pathway ensures that these insights translate directly into timely, personalized treatment plans.
Significant Fall Reduction
Identify and address cardiac-related fall risks early, protecting residents from injuries and improving their safety.
Prevention of Major Cardiac Events
Detect dangerous arrhythmias that can lead to strokes, heart attacks, or sudden cardiac death, enabling prompt intervention.
Streamlined Diagnostic & Treatment Pathways
Seamlessly integrate continuous monitoring data into the CardioElite™ program, facilitating rapid diagnosis and effective management strategies.
Enhanced Resident Well-being
Improve overall patient outcomes and quality of life by providing a more secure and cardiac-attentive care environment.
This vigilant, AI-powered screening process not only mitigates immediate risks but also contributes to the long-term cardiovascular stability of residents. amavita is committed to being a technology leader, continuously incorporating the latest AI innovations to deliver superior, future-proof cardiac care within the SNF setting.
Frequently Asked Questions
What is the amavita CardioElite™ program?
The nation's first cutting-edge AI-powered cardiovascular management system for SNFs, combining exclusive state-of-the-art AI diagnostic technology, a guided pathway to a certification, and extensive staff education.
How does the AI-powered diagnostic technology work?
It leverages the latest AI innovations using a portable, FDA-cleared AI ultrasound for bedside cardiac diagnostics. Real-time guidance ensures accurate imaging, and AI algorithms generate detailed reports on heart structure/function within minutes, enabling early detection and informed decisions.
Why is certification necessary for an SNF?
A certification provides rigorous third-party validation of adherence to high evidence-based care standards for heart failure or stroke. This confirms the facility is equipped with superior protocols and best-in-class AI tools, enhancing credibility, marketability, and increasing referrals from hospitals.
How does CardioElite™ provide ROI?
By leveraging its advanced, data-driven AI, the program significantly reduces preventable hospital readmissions. Research shows a reduction in all-cause readmissions from 27% to 18%, translating to an average of $860 savings per patient.
What challenges does this program address?
It overcomes traditional SNF cardiac care challenges: lack of specialized staff training, resource gaps, and inconsistent care processes, by providing advanced diagnostics powered by continuously evolving AI capabilities, comprehensive education, and an industry-recognized certification framework.
How do internal medicine doctors view CardioElite™?
As a significant benefit and "clinical force multiplier." It equips them with advanced, real-time diagnostic data, derived from cutting-edge AI tools, and 24/7 cardiology consultation, enhancing proactive patient management and reducing emergency workload.
How do cardiologists view CardioElite™?
High cardiovascular readmission rates at SNFs indicate gaps in cardiac care. Traditional episodic models may not meet post-acute needs. The amavita CardioElite™ program offers comprehensive cardiovascular management. It integrates the latest AI innovations, a certification, and staff training for proactive, data-driven care. Rather than a threat, CardioElite™ is an opportunity to improve cardiac services and outcomes. The program transforms an SNF's ability to manage cardiac patients and reduce readmissions.
How do hospitals view an SNF with CardioElite™?
As a highly valuable strategic partner. With proven ability to reduce cardiac readmissions by up to 70% thanks to its advanced AI screening and management, it helps hospitals mitigate penalties, improve quality scores, and ensures a stable flow of high-acuity referrals.
Become a CardioElite™ Center Today
Schedule a Consultation
Contact our team for a personalized assessment of your facility's cardiac care needs.
Implementation Plan
Receive a customized 90-day roadmap for technology integration and staff training.
Begin Transformation
Start delivering superior cardiovascular care and see measurable improvements within the first quarter.
Limited enrollment available for Q4 2025 - Secure your facility's position as a leader in post-acute cardiac care.